McDavid Stilwell | Vice President of Corporate Communications and Investor Relations |
Sandy Macrae | Chief Executive Officer |
Kathy Yi | Chief Financial Officer |
Ed Conner | Chief Medical Officer |
Michael Holmes | Senior Vice President and Chief Technology Officer |
Ritu Baral | Cowen |
Maury Raycroft | Jefferies |
Jim Birchenough | Wells Fargo |
Good morning, and welcome to the Sangamo Therapeutics Teleconference to discuss the First Quarter 2018 Financial Results. This call is being recorded. I will now pass you over to the coordinator of this event, McDavid Stilwell, Vice President of Corporate Communications and Investor Relations.
Good morning, and thank you for joining us.
As we begin, I'd like to point out that we’ll be referring to a slide presentation today.